ImmunoBiotics, Inc.

ImmunoBiotics, Inc., a development stage company, engages in licensing the manufacture, distribution, and sale of nutraceutical products that are made of naturally occurring dietary substances. It licenses LutiMax line of products, including LutiMax 10mg tablets, LutiMax 100mg Lozenges, and LutiSyn Capsules for human consumption and a powder for canine consumption; and LutiSport line of products comprising a lozenge for human consumption, as well as a powder for canine consumption. The company was formerly known as Multinational Merger Corporation and changed its name to ImmunoBiotics, Inc. in August 2007. ImmunoBiotics, Inc. was founded in 2004 and is based in San Clemente, California.